|Bid||12.40 x 1000|
|Ask||12.50 x 800|
|Day's Range||12.40 - 12.63|
|52 Week Range||11.50 - 19.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||24.33|
OTTAWA, ON, Oct.In Canada and around the world, girls are changing their communities and shaping a better future for all of us.
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the appointment of Maria Stahl as chief legal officer.
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...